The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer

• Francesca Di Modugno,

  Affiliation Experimental Chemotherapy, Regina Elena National Cancer Institute, Rome, Italy

  ⨯
• Marcella Mottolese,

  Affiliation Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy

  ⨯
• Lucia DeMonte,

  Affiliations Tumor Immunology, Dibit, San Raffaele Scientific Institute, Milan, Italy, Proteome Biochemistry, Dibit, San Raffaele Scientific Institute, Milan, Italy

  ⨯
• Paola Trono,

  Affiliation Laboratory of Immunology, Regina Elena National Cancer Institute, Rome, Italy

  ⨯
• Michele Balsamo,

  Affiliations Laboratory of Immunology, Regina Elena National Cancer Institute, Rome, Italy, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

  ⨯
• Andrea Conidi,

  Affiliations Laboratory of Immunology, Regina Elena National Cancer Institute, Rome, Italy, Department of Molecular and Developmental Genetics, VIB11, Katholieke Universiteit Leuven, Leuven, Belgium

  ⨯
• Elisa Melucci,

  Affiliation Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy

  ⨯
• Irene Terrenato,

  Affiliation Department of Epidemiology, Regina Elena National Cancer Institute, Rome, Italy

  ⨯
• Francesca Belleudi,

  Affiliation Azienda Ospedaliera S. Andrea, Rome, Italy

  ⨯
• Maria Rosaria Torrisi,

  Affiliation Department of Clinical and Molecular Medicine, University ‘Sapienza’, Rome, Italy

  ⨯
• Massimo Alessio,

  Affiliation Proteome Biochemistry, Dibit, San Raffaele Scientific Institute, Milan, Italy

  ⨯
• Angela Santoni,

  Affiliation Department of Clinical and Molecular Medicine, University ‘Sapienza’, Rome, Italy

  ⨯
• Paola Nisticò

  * E-mail: nistico@ifo.it

  Affiliation Laboratory of Immunology, Regina Elena National Cancer Institute, Rome, Italy

  ⨯